𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No association betweenFMR1premutations and multiple system atrophy

✍ Scribed by Ichiro Yabe; Hiroyuki Soma; Asako Takei; Naoto Fujik; Hidenao Sasaki


Publisher
Springer
Year
2004
Tongue
English
Weight
139 KB
Volume
251
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


SNCA variants and multiple system atroph
✍ Ji Y. Yun; Woong-Woo Lee; Jee-Young Lee; Hee J. Kim; Sung S. Park; Beom S. Jeon πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 3 views
Multiple system atrophy: An update
✍ Gregor K. Wenning; Felix Geser; Michaela Stampfer-Kountchev; FranΓ§ois Tison πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually manifests in the early sixth decade of life and progresses relentlessly with a mean survival of 9 years. Clinically, MSA is dominated by autonomic/urogenital failure, which may be associated with either levodopa (L-d

Survival in multiple system atrophy
✍ Anette Schrag; Gregor K. Wenning; Niall Quinn; Yoav Ben-Shlomo πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract We here report survival in patients with multiple system atrophy (MSA) in a large, prospectively studied group of patients with MSA. Eighty‐five of 100 patients were known to have died. Three patients were rediagnosed as having PD. Twenty‐four patients came to autopsy, which showed MSA